149 related articles for article (PubMed ID: 18978746)
1. Haploidentical SCT in children: an update and future perspectives.
Lang P; Handgretinger R
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S54-9. PubMed ID: 18978746
[TBL] [Abstract][Full Text] [Related]
2. Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Mohty M; Labopin M; Tabrizzi R; Theorin N; Fauser AA; Rambaldi A; Maertens J; Slavin S; Majolino I; Nagler A; Blaise D; Rocha V; ;
Haematologica; 2008 Feb; 93(2):303-6. PubMed ID: 18245655
[TBL] [Abstract][Full Text] [Related]
3. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
Koh LP; Rizzieri DA; Chao NJ
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
[TBL] [Abstract][Full Text] [Related]
5. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.
Koehl U; Sörensen J; Esser R; Zimmermann S; Grüttner HP; Tonn T; Seidl C; Seifried E; Klingebiel T; Schwabe D
Blood Cells Mol Dis; 2004; 33(3):261-6. PubMed ID: 15528141
[TBL] [Abstract][Full Text] [Related]
6. Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?
Dal-Cortivo L; Ouachée-Chardin M; Hirsch I; Blanche S; Fischer A; Cavazzana-Calvo M; Caillat-Zucman S
Bone Marrow Transplant; 2004 Dec; 34(11):945-7. PubMed ID: 15489880
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation.
Blair A; Goulden NJ; Libri NA; Oakhill A; Pamphilon DH
Blood Rev; 2005 Nov; 19(6):289-300. PubMed ID: 16275419
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.
Handgretinger R; Chen X; Pfeiffer M; Mueller I; Feuchtinger T; Hale GA; Lang P
Ann N Y Acad Sci; 2007 Jun; 1106():279-89. PubMed ID: 17442774
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P
Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
Aversa F
Bone Marrow Transplant; 2008 Mar; 41(5):473-81. PubMed ID: 18176612
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
12. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085
[TBL] [Abstract][Full Text] [Related]
13. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
15. The haploidentical option for high-risk haematological malignancies.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2008; 40(1):8-12. PubMed ID: 17905610
[TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning.
Veys P; Rao K; Amrolia P
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S45-7. PubMed ID: 15812530
[TBL] [Abstract][Full Text] [Related]
17. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
[TBL] [Abstract][Full Text] [Related]
18. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
19. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
[TBL] [Abstract][Full Text] [Related]
20. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
Novitzky N; Thomas V; du Toit C; McDonald A
Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
